Product NDC: | 0536-1000 |
Proprietary Name: | Senexon |
Non Proprietary Name: | Sennosides A and B |
Active Ingredient(s): | 8.8 mg/15mL & nbsp; Sennosides A and B |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0536-1000 |
Labeler Name: | The Harvard Drug Group, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20130215 |
Package NDC: | 0536-1000-59 |
Package Description: | 237 mL in 1 BOTTLE, PLASTIC (0536-1000-59) |
NDC Code | 0536-1000-59 |
Proprietary Name | Senexon |
Package Description | 237 mL in 1 BOTTLE, PLASTIC (0536-1000-59) |
Product NDC | 0536-1000 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Sennosides A and B |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20130215 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | The Harvard Drug Group, LLC |
Substance Name | SENNOSIDES A AND B |
Strength Number | 8.8 |
Strength Unit | mg/15mL |
Pharmaceutical Classes |